A crystal diffraction lens for focusing energetic gamma rays has been developed at Argonne National Laboratory for use in medical imaging of radioactivity in the human body. A common method for locating possible cancerous growths in the body is to inject radioactivity into the blood stream of the patient and then look for any concentration of radioactivity that could be associated with the fast growing cancer cells. Often there are borderline indications of possible cancers that could be due to statistical functions in the measured counting rates. In order to determine if these indications are false or real, one must resort to surgical means and take tissue samples in the suspect area. We are developing a system of crystal diffraction lenses that will be incorporated into a 3- D imaging system with better sensitivity (factors of 10 to 20) and better spatial resolution (a few mm in both vertical and horizontal directions) than most systems presently in use. The use of this new imaging system will allow one to eliminate 90 percent of the false indications and both locate and determine the size of the cancer with mm precision. The lens consists of 900 single crystals of copper, 4 mm X 4 mm on a side and 2 - 4 mm thick, mounted in 13 concentric rings.